Overview of Dr. Hansen
Dr. Doris Hansen is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from St. George's University School of Medicine and has been in practice 8 years. She is one of 170 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She has more than 30 publications and over 350 citings.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Fax+1 813-449-6713
Education & Training
University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 2018- University of Mississippi Medical CenterResidency, Internal Medicine, 2012 - 2015
St. George's University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2019 - 2026
MS State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant Start of enrollment: 2022 Apr 20
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 9 citationsThe Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer: A Sys...Doris K Hansen, Yi-Hsuan Liu, Sandip Ranjan, Hitesh Bhandari, Ravi Potluri
Cancers. 2023-12-07 - 40 citationsThe CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.Kai Rejeski, Doris K Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi
Journal of Hematology & Oncology. 2023-07-31 - 35 citationsReal-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk
Blood Cancer Journal. 2023-08-09
Press Mentions
J&J, Legend Solidify Carvykti's Lead in Earlier Multiple Myeloma with Strong Survival ShowingSeptember 30th, 2024- CAR T Puts Moffitt Patient in an Exclusive ClubDecember 19th, 2022
- In Transplant-Ineligible Myeloma, This Frontline Tx Is BetterDecember 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
